Officials raise awareness on new drug, more potent than fentanyl
New synthetic opioid Cychlorphine raises alarm, found to be up to 10 times more potent than fentanyl
17 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 17 separate news trends connected to Dea, spanning June 19, 2026 through September 24, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 173 article observations and 144 source signals, led by Entertainment, Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
New synthetic opioid Cychlorphine raises alarm, found to be up to 10 times more potent than fentanyl
13 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
Hayden Panettiere’s death sparks national focus on fentanyl‑laced prescriptions and a DEA probe of her home
4 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
Nationwide drug‑focused probe into Hayden Panettiere’s death spikes as multiple outlets reveal the cause
13 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
The DEA's sudden ban on a popular kratom compound has left businesses scrambling and legal challenges brewing.
Actress Hayden Panettiere has died, prompting tributes from Rose McGowan and Anna Paquin and scrutiny of her past relationships.
The DEA has joined the investigation into Hayden Panettiere's death, a surprising twist in the probe.
The death of Hayden Panettiere has triggered a Drug Enforcement Agency investigation alongside reports of personal discord involving Brian Hickerson.
Pharmaceutical and drug testing industries warn that President Trump's move to reschedule marijuana will lead to increased abuse.
Public skepticism grows regarding the Trump administration's commitment to federal marijuana rescheduling despite ongoing hearings and court challenges.
The Trump administration's shift in kratom policy sparks debate and scrutiny.
An investigation into a missing woman leads to the discovery of a chemical laboratory, weapons, and fake federal badges in an Olney home.
The DEA is facing scrutiny over transparency and witness testimony during hearings regarding the federal rescheduling of marijuana.
The DEA's upcoming marijuana rescheduling hearing is sparking debate and scrutiny across the cannabis industry.
The DEA is facing scrutiny after inviting only opponents of marijuana rescheduling to a hearing scheduled for June 29th.